Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency

NCT04138251 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Glycogen Storage Disease Type I
Glucose 6 Phosphatase Deficiency

Interventions

DRUG: Empagliflozin

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain